Skip to main content
Clinical Trials/NCT00715819
NCT00715819
Completed
N/A

Use of Otoscope as a Non-invasive Tool for Diagnosis of Pilomatricoma

Stanford University1 site in 1 country4 target enrollmentApril 2008
ConditionsPilomatrixoma

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pilomatrixoma
Sponsor
Stanford University
Enrollment
4
Locations
1
Status
Completed
Last Updated
last year

Overview

Brief Summary

Stanford University Dermatology Clinics and Lucile Packard Children's Hospital are evaluating the use of the otoscope for the diagnosis of skin lesions. We are particularly looking for children and/or adults with nodules, cysts, tumors, or pilomatricomas. The study will take 15-30 minutes and we will use light to examine and take a picture of your skin lesion. There is no monetary compensation for participating in the study.

Detailed Description

Pilomatricoma is a benign tumor that presents as a 3-30mm firm, solitary, deep dermal or subcutaneous tumor on the head, neck, or upper extremities. The clinical diagnosis is often made by the firm, sometimes rock hard texture of the skin. The diagnosis can be confirmed by a skin biopsy and/or excision of the lesion. We have recently noted that pilomatricomas appear as a black mass in the skin when the lesion is transilluminated by placing the light of a fiberoptic otoscope adjacent to the skin lesion. We would like to confirm our impression by a prospective study using transillumination to examine subcutaneous tumors in the skin. Pilomatricoma is also known as a benign calcifying or calcified epithelioma, pilomatrixoma, or a calcifying epithelioma of Malherbe.

Registry
clinicaltrials.gov
Start Date
April 2008
End Date
January 2010
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Potential participants will be any patient that is seen at Stanford Dermatology or LPCH that has a cyst, nodule, vesicle, tumor, or possible pilomatricoma

Exclusion Criteria

  • Inability of subject or subject's guardian to understand informed consent form.

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials